Showing results (1461-1470 of 1,659) with videos related to
Sort By:
Pageof 166
European Journal of Medicinal Chemistry|April 9, 2026
Fine-tuning the combination of novel spirocyclic capping moieties and heterocyclic zinc binding groups for selective HDAC6 inhibition: design, synthesis, kinetic and biological studiesSimona Barone, Ivana Bello, Gessica Filocamo, et al.Diabetes, Obesity & Metabolism|August 5, 2025
Efficacy and safety of CT-868, a novel, fully biased, dual glucagon-like peptide-1/glucose-dependent insulinotropic polypeptide receptor agonist, in type 2 diabetes: A double-blind, randomized placebo controlled phase 2 trialManu V Chakravarthy, Michael A Elliott, Luis Acosta, et al.RSC Chemical Biology|November 2, 2022
The covalent reactivity of functionalized 5-hydroxy-butyrolactams is the basis for targeting of fatty acid binding protein 5 (FABP5) by the neurotrophic agent MT-21Esben B Svenningsen, Rasmus N Ottosen, Katrine H Jørgensen, et al.AJNR. American Journal of Neuroradiology|May 13, 2017
Mechanical Thrombectomy with the Embolus Retriever with Interlinked Cages in Acute Ischemic Stroke: ERIC, the New Boy in the ClassH Steglich-Arnholm, D Kondziella, A Wagner, et al.Antiviral Therapy|September 14, 2010
Z-FA-FMK as a novel potent inhibitor of reovirus pathogenesis and oncolysis in vivoManbok Kim, Kristina K Hansen, Lesley Davis, et al.Biochemical Pharmacology|July 1, 2008
Development of XPA067.06, a potent high affinity human anti-gastrin monoclonal antibodySsucheng J Hsu, Amita Patel, Paul D Larsen, et al.Journal of Medicinal Chemistry|June 6, 2017
Alkoxyurea-Based Histone Deacetylase Inhibitors Increase Cisplatin Potency in Chemoresistant Cancer Cell LinesKatharina Stenzel, Alexandra Hamacher, Finn K Hansen, et al.Resuscitation|April 14, 2019
Vasopressors during adult cardiac arrest: A systematic review and meta-analysisMathias J Holmberg, Mahmoud S Issa, Ari Moskowitz, et al.Diabetologia|August 20, 2021
Effects of the SGLT2 inhibitor canagliflozin on plasma biomarkers TNFR-1, TNFR-2 and KIM-1 in the CANVAS trialTaha Sen, Jingwei Li, Brendon L Neuen, et al.Circulation|August 21, 2023
Cardiorenal Biomarkers, Canagliflozin, and Outcomes in Diabetic Kidney Disease: The CREDENCE TrialJames L Januzzi, Reza Mohebi, Yuxi Liu, et al.Pageof 166